ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Income Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹809 Cr | ₹817 Cr | ₹835 Cr | ₹732 Cr | ₹572 Cr |
Sales | ₹765 Cr | ₹780 Cr | ₹805 Cr | ₹687 Cr | ₹528 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹44 Cr | ₹32 Cr | ₹31 Cr | ₹24 Cr | ₹30 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | ₹5.00 Cr | ₹0.04 Cr | ₹21 Cr | ₹14 Cr |
Less: Excise Duty | - | - | - | - | ₹0.99 Cr |
Net Sales | ₹806 Cr | ₹814 Cr | ₹832 Cr | ₹728 Cr | ₹571 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹14 Cr | ₹2.95 Cr | ₹-39 Cr | ₹-1.38 Cr | ₹-51 Cr |
Raw Material Consumed | ₹291 Cr | ₹284 Cr | ₹339 Cr | ₹228 Cr | ₹229 Cr |
Opening Raw Materials | ₹20 Cr | ₹21 Cr | ₹12 Cr | ₹10.00 Cr | ₹7.03 Cr |
Purchases Raw Materials | ₹77 Cr | ₹89 Cr | ₹74 Cr | ₹60 Cr | ₹28 Cr |
Closing Raw Materials | ₹14 Cr | ₹20 Cr | ₹21 Cr | ₹12 Cr | ₹10.00 Cr |
Other Direct Purchases / Brought in cost | ₹208 Cr | ₹195 Cr | ₹274 Cr | ₹170 Cr | ₹204 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹8.10 Cr | ₹7.37 Cr | ₹7.72 Cr | ₹8.27 Cr | ₹8.30 Cr |
Electricity & Power | ₹8.10 Cr | ₹7.37 Cr | ₹7.72 Cr | ₹8.27 Cr | ₹8.30 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹230 Cr | ₹220 Cr | ₹217 Cr | ₹197 Cr | ₹150 Cr |
Salaries, Wages & Bonus | ₹199 Cr | ₹192 Cr | ₹188 Cr | ₹171 Cr | ₹128 Cr |
Contributions to EPF & Pension Funds | ₹11 Cr | ₹11 Cr | ₹9.58 Cr | ₹9.07 Cr | ₹7.21 Cr |
Workmen and Staff Welfare Expenses | ₹13 Cr | ₹11 Cr | ₹14 Cr | ₹12 Cr | ₹9.18 Cr |
Other Employees Cost | ₹6.49 Cr | ₹5.87 Cr | ₹4.85 Cr | ₹4.75 Cr | ₹6.38 Cr |
Other Manufacturing Expenses | ₹57 Cr | ₹49 Cr | ₹41 Cr | ₹50 Cr | ₹51 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹4.94 Cr | ₹6.08 Cr | ₹6.41 Cr | ₹6.68 Cr | ₹5.33 Cr |
Packing Material Consumed | ₹6.68 Cr | ₹7.65 Cr | ₹5.26 Cr | ₹4.40 Cr | ₹2.31 Cr |
Other Mfg Exp | ₹46 Cr | ₹36 Cr | ₹29 Cr | ₹39 Cr | ₹43 Cr |
General and Administration Expenses | ₹40 Cr | ₹41 Cr | ₹66 Cr | ₹74 Cr | ₹46 Cr |
Rent , Rates & Taxes | ₹2.01 Cr | ₹3.02 Cr | ₹3.92 Cr | ₹9.02 Cr | ₹6.60 Cr |
Insurance | ₹2.70 Cr | ₹3.04 Cr | ₹3.01 Cr | ₹3.04 Cr | ₹2.58 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹21 Cr | ₹24 Cr | ₹24 Cr | ₹20 Cr | ₹12 Cr |
Traveling and conveyance | ₹10 Cr | ₹5.78 Cr | ₹31 Cr | ₹39 Cr | ₹22 Cr |
Other Administration | ₹14 Cr | ₹11 Cr | ₹35 Cr | ₹42 Cr | ₹25 Cr |
Selling and Distribution Expenses | ₹62 Cr | ₹56 Cr | ₹65 Cr | ₹88 Cr | ₹81 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹51 Cr | ₹45 Cr | ₹56 Cr | ₹80 Cr | ₹73 Cr |
Miscellaneous Expenses | ₹17 Cr | ₹18 Cr | ₹15 Cr | ₹13 Cr | ₹9.58 Cr |
Bad debts /advances written off | ₹0.29 Cr | - | - | - | - |
Provision for doubtful debts | ₹4.00 Cr | ₹2.72 Cr | ₹1.58 Cr | ₹3.45 Cr | ₹0.59 Cr |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.13 Cr | ₹0.54 Cr | ₹0.44 Cr | - | ₹0.33 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹12 Cr | ₹15 Cr | ₹13 Cr | ₹9.29 Cr | ₹8.66 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹719 Cr | ₹678 Cr | ₹711 Cr | ₹657 Cr | ₹525 Cr |
Operating Profit (Excl OI) | ₹86 Cr | ₹135 Cr | ₹121 Cr | ₹71 Cr | ₹46 Cr |
Other Income | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹16 Cr | ₹12 Cr |
Interest Received | ₹11 Cr | ₹10 Cr | ₹12 Cr | ₹15 Cr | ₹11 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹2.82 Cr | ₹2.17 Cr | ₹0.29 Cr | ₹0.06 Cr | ₹0.01 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | - | - | ₹0.66 Cr | - |
Others | ₹0.46 Cr | ₹0.21 Cr | ₹0.47 Cr | ₹0.20 Cr | ₹0.90 Cr |
Operating Profit | ₹101 Cr | ₹148 Cr | ₹134 Cr | ₹88 Cr | ₹59 Cr |
Interest | ₹0.95 Cr | ₹1.09 Cr | ₹1.14 Cr | - | - |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹0.95 Cr | ₹1.09 Cr | ₹1.14 Cr | - | - |
PBDT | ₹100 Cr | ₹147 Cr | ₹133 Cr | ₹88 Cr | ₹59 Cr |
Depreciation | ₹17 Cr | ₹20 Cr | ₹19 Cr | ₹15 Cr | ₹15 Cr |
Profit Before Taxation & Exceptional Items | ₹83 Cr | ₹127 Cr | ₹114 Cr | ₹73 Cr | ₹44 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹83 Cr | ₹127 Cr | ₹114 Cr | ₹73 Cr | ₹44 Cr |
Provision for Tax | ₹21 Cr | ₹34 Cr | ₹42 Cr | ₹18 Cr | ₹18 Cr |
Current Income Tax | ₹23 Cr | ₹34 Cr | ₹32 Cr | ₹24 Cr | - |
Deferred Tax | ₹-1.19 Cr | ₹-1.04 Cr | ₹10 Cr | ₹1.54 Cr | ₹8.89 Cr |
Other taxes | - | ₹1.23 Cr | - | ₹-7.51 Cr | ₹18 Cr |
Profit After Tax | ₹62 Cr | ₹93 Cr | ₹72 Cr | ₹54 Cr | ₹26 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹62 Cr | ₹93 Cr | ₹72 Cr | ₹54 Cr | ₹26 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹324 Cr | ₹232 Cr | ₹168 Cr | ₹114 Cr | ₹91 Cr |
Appropriations | ₹386 Cr | ₹326 Cr | ₹240 Cr | ₹169 Cr | ₹117 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | ₹0.51 Cr | - | - |
Other Appropriation | ₹1.74 Cr | ₹-3.43 Cr | ₹4.92 Cr | ₹0.60 Cr | ₹2.28 Cr |
Equity Dividend % | ₹500.00 | ₹100.00 | ₹50.00 | - | - |
Earnings Per Share | ₹24.64 | ₹37.32 | ₹28.88 | ₹21.78 | ₹10.36 |
Adjusted EPS | ₹24.64 | ₹37.32 | ₹28.88 | ₹21.78 | ₹10.36 |
Compare Income Statement of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹13,353.1 Cr | 1.4% | 0.4% | 75.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 1.4% |
0.4% |
75.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses